Transmedics Group Inc reports results for the quarter ended June 30 - Earnings Summary

TransMedics

30/07/2025 22:03

Transmedics Group Inc TMDX.OQ reported quarterly adjusted earnings of 92 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 35 cents.  The mean expectation of ten analysts for the quarter was for earnings of 45 cents per share. Wall Street expected results to range from 34 cents to 59 cents per share.

Revenue rose 37.7% to $157.37 million from a year ago; analysts expected $147.86 million.

Transmedics Group Inc's reported EPS for the quarter was 92 cents​.

The company reported quarterly net income of $34.91 million.

Transmedics Group Inc shares had fallen by 21.8% this quarter and gained 68.1% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 24.7% in the last three months.​

In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Transmedics Group Inc is $149.00, about 29.6% above its last closing price of $104.83

This summary was machine generated from LSEG data July 30 at 09:02 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
0.45
0.92
Beat
Mar. 31 2025
0.26
0.70
Beat
Dec. 31 2024
0.16
0.19
Beat
Sep. 30 2024
0.29
0.12
Missed